|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tumorassociated hyaluronic acid: a new sensitive and specific urine marker for bladder cancer显示文摘 | Lokeshwar VB Obek C Soloway MS | 1997 | Cancer Res1997，57，4： | 1 |
| 2 | Use of a new tumer maker , urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment显示文摘 | Soloway MS Briggman JV Carpinito GA | 1996 | J Urol1996，156，21： | 1 |
| 3 | Office evaluation and management of bladder neoplasm显示文摘 | Soloway MS | 1998 | Urol Clin North Am1998，25，： | 1 |
| 4 | Intravesicaltherapy options for bladder malignancy显示文摘 | Bird VG Soloway MS | | 0，，05： | 1 |
| 5 | Dramatic reduction in tumor burden with neoadjuvant sunitinib prior to bilateral neph- ton - sparing surgery 显示文摘 | Gorin MA Ekwenna O Soloway MS | 2012 | Urology2012，79，2： | 1 |
| 6 | Flexible cystourethroscopy : Alterative to rigid instruments for evaluation of lower urinary tract显示文摘 | | 1985 | Urology1985，25，： | 1 |
| 7 | Use a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment 显示文摘 | Soloway MS Briggman JV Carpinito GA | 1996 | J Urol1996，156，： | 1 |
| 8 | Stratification of patients with metastatic cancer based on extent of disease on initial bone scan显示文摘 | Soloway MS Hardeman SW Hickey D | 1998 | Cancer1998，61，1： | 1 |
| 9 | Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment显示文摘 | Soloway MS Briggman V Carpinito GA | 1996 | J Urol1996，156，21： | 1 |
| 10 | Complications of intravesical therapy for urothelial cancer of the bladder显示文摘 | Koya MP Simon MA Soloway MS | 2006 | J Urol2006，179，： | 1 |
| 11 | Use of anew tumor marker,Urinary NMP22,in the detection ofoccult or rapidly recurring transitional cell carcinoma ofthe urinary tract following surgical treatment显示文摘 | Soloway MS BriggmanJV Carpinito GA | 1996 | JUrol1996，，： | 1 |
| 12 | The management of superficial bladder cancer显示文摘 | | 1980 | Cancer1980，45，9： | 1 |
| 13 | Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment显示文摘 | Soloway MS Briggman V Curpinito GA | 1996 | J Urol1996，156，： | 1 |
| 14 | Intravesical therapy for bladder cancer显示文摘 | Soloway MS | 1980 | Vrol ClinNorth Am1980，15，： | 1 |
| 15 | Results of a multicenter trial using the BTA-test to monitor for and diagnose recurrent bladder cancer显示文摘 | Sarosdy MF De-Vere-White RW Soloway MS | 1995 | J Urol1995，154，2： | 1 |
| 16 | Use of anew marker,urinary NMP22 ,in the detectiong of occult ot rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment显示文摘 | Soloway MS Briggman JV Carpinmto GA | 1996 | J Urol1996，156，21： | 1 |
| 17 | Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan显示文摘 | Soloway MS Hardeman SW Frcsi DH | 1988 | Cancer1988，61，1： | 1 |
| 18 | Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer 显示文摘 | Sarosdy MF White RW Soloway MS | 1995 | J Urol1995，154，21： | 1 |
| 19 | Stratification of patients with metastatic cancer based on extent of disease on initial bone scan显示文摘 | Soloway MS Hardeman SW Hickey D | 1988 | Cancer1988，61，1： | 1 |
| 20 | Use of a new tumor marker,urinary NMP22,in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment显示文摘 | Soloway MS Briggman V Carpinito GA | 1996 | J Urol1996，156，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员